chr3-94053229-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_001174150.2(ARL13B):c.1253G>A(p.Arg418Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000348 in 1,613,250 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001174150.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL13B | NM_001174150.2 | c.1253G>A | p.Arg418Gln | missense_variant | 10/10 | ENST00000394222.8 | NP_001167621.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARL13B | ENST00000394222.8 | c.1253G>A | p.Arg418Gln | missense_variant | 10/10 | 1 | NM_001174150.2 | ENSP00000377769.3 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152084Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000355 AC: 89AN: 250876Hom.: 0 AF XY: 0.000398 AC XY: 54AN XY: 135626
GnomAD4 exome AF: 0.000359 AC: 524AN: 1461048Hom.: 1 Cov.: 31 AF XY: 0.000351 AC XY: 255AN XY: 726854
GnomAD4 genome AF: 0.000250 AC: 38AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74404
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2022 | ARL13B: BP4, BP5 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 08, 2024 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 18674751) - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Joubert syndrome 8 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 12, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 25, 2022 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 418 of the ARL13B protein (p.Arg418Gln). This variant is present in population databases (rs142510905, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with ARL13B-related conditions. ClinVar contains an entry for this variant (Variation ID: 546147). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2023 | The c.1253G>A (p.R418Q) alteration is located in exon 10 (coding exon 10) of the ARL13B gene. This alteration results from a G to A substitution at nucleotide position 1253, causing the arginine (R) at amino acid position 418 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at